메뉴 건너뛰기




Volumn 111, Issue 37, 2014, Pages 13421-13426

Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma

Author keywords

EIF4A; Hippuristanol; RNAi screening; Silvestrol

Indexed keywords

DEXAMETHASONE; INITIATION FACTOR 4F; MCL1 PROTEIN, HUMAN; MYC PROTEIN; PROTEIN MCL 1; SILVESTROL; TRITERPENE;

EID: 84907259417     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1402650111     Document Type: Article
Times cited : (50)

References (37)
  • 1
    • 79951494668 scopus 로고    scopus 로고
    • Initial genome sequencing and analysis of multiple myeloma
    • Chapman MA, et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471(7339):467-472.
    • (2011) Nature , vol.471 , Issue.7339 , pp. 467-472
    • Chapman, M.A.1
  • 2
    • 64749098712 scopus 로고    scopus 로고
    • Multiple myeloma: Biology, standard therapy, and transplant therapy
    • Gertz MA, Ghobrial I, Luc-Harousseau J (2009) Multiple myeloma: Biology, standard therapy, and transplant therapy. Biol Blood Marrow Transplant 15(1, Suppl):46-52.
    • (2009) Biol Blood Marrow Transplant , vol.15 , Issue.1 , pp. 46-52
    • Gertz, M.A.1    Ghobrial, I.2    Luc-Harousseau, J.3
  • 3
    • 67349241955 scopus 로고    scopus 로고
    • DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival
    • Peterson TR, et al. (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137(5):873-886.
    • (2009) Cell , vol.137 , Issue.5 , pp. 873-886
    • Peterson, T.R.1
  • 5
    • 48549094467 scopus 로고    scopus 로고
    • C-Myc and eIF4F are components of a feedforward loop that links transcription and translation
    • Lin CJ, Cencic R, Mills JR, Robert F, Pelletier J (2008) c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res 68(13): 5326-5334.
    • (2008) Cancer Res , vol.68 , Issue.13 , pp. 5326-5334
    • Lin, C.J.1    Cencic, R.2    Mills, J.R.3    Robert, F.4    Pelletier, J.5
  • 6
    • 0034602691 scopus 로고    scopus 로고
    • Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma
    • Shou Y, et al. (2000) Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc Natl Acad Sci USA 97(1):228-233.
    • (2000) Proc Natl Acad Sci USA , vol.97 , Issue.1 , pp. 228-233
    • Shou, Y.1
  • 7
    • 79958095463 scopus 로고    scopus 로고
    • Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
    • Chng WJ, et al. (2011) Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma. Leukemia 25(6):1026-1035.
    • (2011) Leukemia , vol.25 , Issue.6 , pp. 1026-1035
    • Chng, W.J.1
  • 8
    • 32844456419 scopus 로고    scopus 로고
    • Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis
    • Kanungo A, Medeiros LJ, Abruzzo LV, Lin P (2006) Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 19(1):25-33.
    • (2006) Mod Pathol , vol.19 , Issue.1 , pp. 25-33
    • Kanungo, A.1    Medeiros, L.J.2    Abruzzo, L.V.3    Lin, P.4
  • 9
    • 0027289462 scopus 로고
    • Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc
    • Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV (1993) Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci USA 90(13):6175-6178.
    • (1993) Proc Natl Acad Sci USA , vol.90 , Issue.13 , pp. 6175-6178
    • Rosenwald, I.B.1    Rhoads, D.B.2    Callanan, L.D.3    Isselbacher, K.J.4    Schmidt, E.V.5
  • 10
    • 1642586272 scopus 로고    scopus 로고
    • Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
    • Wendel HG, et al. (2004) Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428(6980):332-337.
    • (2004) Nature , vol.428 , Issue.6980 , pp. 332-337
    • Wendel, H.G.1
  • 11
    • 80053203115 scopus 로고    scopus 로고
    • The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma
    • Gera J, Lichtenstein A (2011) The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma. Leuk Lymphoma 52(10):1857-1866.
    • (2011) Leuk Lymphoma , vol.52 , Issue.10 , pp. 1857-1866
    • Gera, J.1    Lichtenstein, A.2
  • 12
    • 10244260355 scopus 로고    scopus 로고
    • Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
    • Raje N, et al. (2004) Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma. Blood 104(13):4188-4193.
    • (2004) Blood , vol.104 , Issue.13 , pp. 4188-4193
    • Raje, N.1
  • 13
    • 27644534999 scopus 로고    scopus 로고
    • Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade
    • Shi Y, Yan H, Frost P, Gera J, Lichtenstein A (2005) Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. Mol Cancer Ther 4(10):1533-1540.
    • (2005) Mol Cancer Ther , vol.4 , Issue.10 , pp. 1533-1540
    • Shi, Y.1    Yan, H.2    Frost, P.3    Gera, J.4    Lichtenstein, A.5
  • 14
    • 67650995912 scopus 로고    scopus 로고
    • Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235
    • McMillin DW, et al. (2009) Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. Cancer Res 69(14):5835-5842.
    • (2009) Cancer Res , vol.69 , Issue.14 , pp. 5835-5842
    • McMillin, D.W.1
  • 15
    • 78649471733 scopus 로고    scopus 로고
    • Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor
    • Hoang B, et al. (2010) Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor. Blood 116(22):4560-4568.
    • (2010) Blood , vol.116 , Issue.22 , pp. 4560-4568
    • Hoang, B.1
  • 16
    • 84880352272 scopus 로고    scopus 로고
    • Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers
    • Pourdehnad M, et al. (2013) Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proc Natl Acad Sci USA 110(29):11988-11993.
    • (2013) Proc Natl Acad Sci USA , vol.110 , Issue.29 , pp. 11988-11993
    • Pourdehnad, M.1
  • 17
    • 17444440115 scopus 로고    scopus 로고
    • Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone
    • Strömberg T, et al. (2004) Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. Blood 103(8):3138-3147.
    • (2004) Blood , vol.103 , Issue.8 , pp. 3138-3147
    • Strömberg, T.1
  • 18
    • 33644516582 scopus 로고    scopus 로고
    • Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis
    • Yan H, et al. (2006) Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis. Cancer Res 66(4):2305-2313.
    • (2006) Cancer Res , vol.66 , Issue.4 , pp. 2305-2313
    • Yan, H.1
  • 19
    • 0038824960 scopus 로고    scopus 로고
    • How myeloma cells escape bisphosphonate- mediated killing: Development of specific resistance with preserved sensitivity to conventional chemotherapeutics
    • Salomo M, Jurlander J, Nielsen LB, Gimsing P (2003) How myeloma cells escape bisphosphonate- mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeutics. Br J Haematol 122(2):202-210.
    • (2003) Br J Haematol , vol.122 , Issue.2 , pp. 202-210
    • Salomo, M.1    Jurlander, J.2    Nielsen, L.B.3    Gimsing, P.4
  • 20
    • 0031415218 scopus 로고    scopus 로고
    • A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death
    • D'Adamio F, et al. (1997) A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7(6): 803-812.
    • (1997) Immunity , vol.7 , Issue.6 , pp. 803-812
    • D'adamio, F.1
  • 21
    • 0031982683 scopus 로고    scopus 로고
    • A novel functional human eukaryotic translation initiation factor 4G
    • Gradi A, et al. (1998) A novel functional human eukaryotic translation initiation factor 4G. Mol Cell Biol 18(1):334-342.
    • (1998) Mol Cell Biol , vol.18 , Issue.1 , pp. 334-342
    • Gradi, A.1
  • 22
    • 0032834055 scopus 로고    scopus 로고
    • EIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation
    • Gingras AC, Raught B, Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68: 913-963.
    • (1999) Annu Rev Biochem , vol.68 , pp. 913-963
    • Gingras, A.C.1    Raught, B.2    Sonenberg, N.3
  • 23
    • 84862520790 scopus 로고    scopus 로고
    • A cellular response linking eIF4AI activity to eIF4AII transcription
    • Galicia-Vázquez G, Cencic R, Robert F, Agenor AQ, Pelletier J (2012) A cellular response linking eIF4AI activity to eIF4AII transcription. RNA 18(7):1373-1384.
    • (2012) RNA , vol.18 , Issue.7 , pp. 1373-1384
    • Galicia-Vázquez, G.1    Cencic, R.2    Robert, F.3    Agenor, A.Q.4    Pelletier, J.5
  • 24
    • 38849180436 scopus 로고    scopus 로고
    • Targeting the eukaryotic translation initiation factor 4E for cancer therapy
    • Graff JR, Konicek BW, Carter JH, Marcusson EG (2008) Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 68(3):631-634.
    • (2008) Cancer Res , vol.68 , Issue.3 , pp. 631-634
    • Graff, J.R.1    Konicek, B.W.2    Carter, J.H.3    Marcusson, E.G.4
  • 25
    • 84867760869 scopus 로고    scopus 로고
    • Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors
    • Liu T, et al. (2012) Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors. J Med Chem 55(20):8859-8878.
    • (2012) J Med Chem , vol.55 , Issue.20 , pp. 8859-8878
    • Liu, T.1
  • 26
    • 65549098672 scopus 로고    scopus 로고
    • Antitumor activity and mechanism of action of the cyclopenta [b]benzofuran, silvestrol
    • Cencic R, et al. (2009) Antitumor activity and mechanism of action of the cyclopenta [b]benzofuran, silvestrol. PLoS ONE 4(4):e5223.
    • (2009) PLoS ONE , vol.4 , Issue.4 , pp. e5223
    • Cencic, R.1
  • 27
    • 2342489456 scopus 로고    scopus 로고
    • EIF-4E expression and its role in malignancies and metastases
    • De Benedetti A, Graff JR (2004) eIF-4E expression and its role in malignancies and metastases. Oncogene 23(18):3189-3199.
    • (2004) Oncogene , vol.23 , Issue.18 , pp. 3189-3199
    • De Benedetti, A.1    Graff, J.R.2
  • 28
    • 37249042829 scopus 로고    scopus 로고
    • Dissecting eIF4E action in tumorigenesis
    • Wendel HG, et al. (2007) Dissecting eIF4E action in tumorigenesis. Genes Dev 21(24): 3232-3237.
    • (2007) Genes Dev , vol.21 , Issue.24 , pp. 3232-3237
    • Wendel, H.G.1
  • 29
    • 21744457447 scopus 로고    scopus 로고
    • Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
    • Wuillème-Toumi S, et al. (2005) Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival. Leukemia 19(7):1248-1252.
    • (2005) Leukemia , vol.19 , Issue.7 , pp. 1248-1252
    • Wuillème-Toumi, S.1
  • 30
    • 0037468570 scopus 로고    scopus 로고
    • IL-6-independent expression of Mcl-1 in human multiple myeloma
    • Zhang B, Potyagaylo V, Fenton RG (2003) IL-6-independent expression of Mcl-1 in human multiple myeloma. Oncogene 22(12):1848-1859.
    • (2003) Oncogene , vol.22 , Issue.12 , pp. 1848-1859
    • Zhang, B.1    Potyagaylo, V.2    Fenton, R.G.3
  • 31
    • 84860729291 scopus 로고    scopus 로고
    • The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction
    • Descamps G, et al. (2012) The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction. Br J Cancer 106(10):1660-1667.
    • (2012) Br J Cancer , vol.106 , Issue.10 , pp. 1660-1667
    • Descamps, G.1
  • 32
    • 80053070033 scopus 로고    scopus 로고
    • PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis
    • Ilic N, Utermark T, Widlund HR, Roberts TM (2011) PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis. Proc Natl Acad Sci USA 108(37):E699-E708.
    • (2011) Proc Natl Acad Sci USA , vol.108 , Issue.37 , pp. E699-E708
    • Ilic, N.1    Utermark, T.2    Widlund, H.R.3    Roberts, T.M.4
  • 33
    • 0029807699 scopus 로고    scopus 로고
    • Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines
    • Hala M, Hartmann BL, Böck G, Geley S, Kofler R (1996) Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines. Int J Cancer 68(5):663-668.
    • (1996) Int J Cancer , vol.68 , Issue.5 , pp. 663-668
    • Hala, M.1    Hartmann, B.L.2    Böck, G.3    Geley, S.4    Kofler, R.5
  • 34
    • 0022516366 scopus 로고
    • Glucocorticoid receptors and glucocorticoid resistance in human leukemia in vivo and in vitro
    • Thompson EB, Harmon JM (1986) Glucocorticoid receptors and glucocorticoid resistance in human leukemia in vivo and in vitro. Adv Exp Med Biol 196:111-127.
    • (1986) Adv Exp Med Biol , vol.196 , pp. 111-127
    • Thompson, E.B.1    Harmon, J.M.2
  • 35
    • 0035187441 scopus 로고    scopus 로고
    • Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: Importance of the ligand-binding domain for intracellular GR trafficking
    • Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP (2001) Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: Importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 86(11):5600-5608.
    • (2001) J Clin Endocrinol Metab , vol.86 , Issue.11 , pp. 5600-5608
    • Kino, T.1    Stauber, R.H.2    Resau, J.H.3    Pavlakis, G.N.4    Chrousos, G.P.5
  • 36
    • 33846187629 scopus 로고    scopus 로고
    • Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells
    • Sánchez-Vega B, Krett N, Rosen ST, Gandhi V (2006) Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells. Mol Cancer Ther 5(12): 3062-3070.
    • (2006) Mol Cancer Ther , vol.5 , Issue.12 , pp. 3062-3070
    • Sánchez-Vega, B.1    Krett, N.2    Rosen, S.T.3    Gandhi, V.4
  • 37
    • 33749443714 scopus 로고    scopus 로고
    • Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance
    • Wei G, et al. (2006) Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10(4):331-342.
    • (2006) Cancer Cell , vol.10 , Issue.4 , pp. 331-342
    • Wei, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.